Accrued Expenses

3 Months Ended

Mar. 31, 2017

6.	ACCRUED EXPENSES

Accrued expenses consisted of the following:

	March 31, 2017		December 31, 2016
Accrued clinical operations and trials costs	$	1,333,114	$	1,647,490
Accrued product development costs		1,246,527		713,426
Accrued compensation		122,175		778,250
Accrued other		172,302		117,289
Total	$	2,874,118	$	3,256,455